Featuring an interview with Dr Charles Powell, including the following topics:
- Role of the pulmonologist in the cancer care team; frequency of fatal and Grade 4 interstitial lung disease (ILD) with antibody-drug conjugates (0:00)
- Pathophysiology of pneumonitis associated with checkpoint inhibitors versus antibody-drug conjugates; differences in presentation of ILD based on the cause of disease (8:04)
- Myths and misperceptions about drug-related pneumonitis among general medical oncologists (14:08)
- Monitoring for the onset of ILD using remote technology; typical time to onset of ILD (21:45)
- Risk factors for the development of ILD among patients receiving anticancer therapy (25:58)
- Incidence of ILD with bispecific antibodies; mechanisms underlying differences in the incidence of ILD associated with various antibody-drug conjugates (33:45)
CME information and select publications
Research To Practice | Oncology Videos